Release of granule proteins from human eosinophils stimulated with mast-cell mediators - PubMed (original) (raw)

Release of granule proteins from human eosinophils stimulated with mast-cell mediators

S Takafuji et al. Allergy. 1998 Oct.

Abstract

Background: It has been suggested that mast cells and eosinophils are major effector cells in the pathogenesis of allergic diseases. However, the interaction of these cells has not been thoroughly elucidated. We examined eosinophil cationic protein (ECP) release and cytosolic free calcium concentration ([Ca2+]i) in human eosinophils induced by the major mast-cell mediators including cytokines.

Methods: Eosinophils from healthy donors were stimulated with the major mast-cell mediators for 20 min after preincubation with cytochalasin B for 10 min. ECP in supernatants was measured by radioimmunoassay. Moreover, to examine changes of [Ca2+]i in eosinophils, Fura-2-loaded eosinophils were monitored for fluorescence changes after stimulus addition.

Results: Of the tested mediators (prostaglandin [PG]D2, leukotriene (LT)B4, platelet-activating factor (PAF), histamine, LTC4, and eosinophil chemotactic factor of anaphylaxis [ECF-A]), LTB4 and PAF induced ECP release from eosinophils. Any cytokines produced by human mast cells, i.e., interleukin (IL)-4, IL-5, IL-8, tumor necrosis factor (TNF), or granulocyte-macrophage colony-stimulating factor (GM-CSF), did not induce ECP release in our system. ECP release triggered with LTB4 and PAF occurred at concentrations of 10(-8)-10(-6) M concentration-dependently. LTB4 and PAF also elicited a rise in [Ca2+]i in eosinophils. Neither PGD2, histamine, nor LTC4 induced ECP release, although they increased cytosolic calcium in eosinophils.

Conclusions: Of mast-cell mediators, LTB4 and PAF induced eosinophil degranulation. The contribution of LTB4 and PAF from mast cells to eosinophil degranulation may be important in the pathogenesis of allergic inflammatory diseases.

PubMed Disclaimer

Cited by

Open-label, add-on trial of cetirizine for neuromyelitis optica.
Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin FD. Katz Sand I, et al. Neurol Neuroimmunol Neuroinflamm. 2018 Feb 2;5(2):e441. doi: 10.1212/NXI.0000000000000441. eCollection 2018 Mar. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30426035 Free PMC article.
Genetic variants of RNASE3 (ECP) and susceptibility to severe malaria in Senegalese population.
Diop G, Derbois C, Loucoubar C, Mbengue B, Ndao BN, Thiam F, Thiam A, Ndiaye R, Dieye Y, Olaso R, Deleuze JF, Dieye A. Diop G, et al. Malar J. 2018 Feb 5;17(1):61. doi: 10.1186/s12936-018-2205-9. Malar J. 2018. PMID: 29402293 Free PMC article.
Eosinophils in fungus-associated allergic pulmonary disease.
Ghosh S, Hoselton SA, Dorsam GP, Schuh JM. Ghosh S, et al. Front Pharmacol. 2013 Feb 1;4:8. doi: 10.3389/fphar.2013.00008. eCollection 2013. Front Pharmacol. 2013. PMID: 23378838 Free PMC article.
Polymorphisms in the RNASE3 gene are associated with susceptibility to cerebral malaria in Ghanaian children.
Adu B, Dodoo D, Adukpo S, Gyan BA, Hedley PL, Goka B, Adjei GO, Larsen SO, Christiansen M, Theisen M. Adu B, et al. PLoS One. 2011;6(12):e29465. doi: 10.1371/journal.pone.0029465. Epub 2011 Dec 27. PLoS One. 2011. PMID: 22216286 Free PMC article.
LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects.
Widegren H, Andersson M, Borgeat P, Flamand L, Johnston S, Greiff L. Widegren H, et al. Respir Med. 2011 Jul;105(7):997-1006. doi: 10.1016/j.rmed.2010.12.021. Epub 2011 Jan 19. Respir Med. 2011. PMID: 21251805 Free PMC article. Clinical Trial.

Release of granule proteins from human eosinophils stimulated with mast-cell mediators - PubMed (original) (raw)